fda and tirzepatide is FDA-approved for weight management, with clinical trials showing average weight loss of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, it works by acting FDA's tirzepatide decision creates uncertainty
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7





![Anti-Glutathione Peroxidase 2/GPX2 antibody [EPR8175(2)]](https://content.abcam.com/products/images/glutathione-peroxidase-2-gpx2-antibody-epr81752-ab140130--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img96274.jpg)




















